JPWO2023283586A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023283586A5
JPWO2023283586A5 JP2024500046A JP2024500046A JPWO2023283586A5 JP WO2023283586 A5 JPWO2023283586 A5 JP WO2023283586A5 JP 2024500046 A JP2024500046 A JP 2024500046A JP 2024500046 A JP2024500046 A JP 2024500046A JP WO2023283586 A5 JPWO2023283586 A5 JP WO2023283586A5
Authority
JP
Japan
Prior art keywords
unsubstituted
substituted
alkyl
virus
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529291A5 (https=
JP2024529291A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073476 external-priority patent/WO2023283586A2/en
Publication of JP2024529291A publication Critical patent/JP2024529291A/ja
Publication of JP2024529291A5 publication Critical patent/JP2024529291A5/ja
Publication of JPWO2023283586A5 publication Critical patent/JPWO2023283586A5/ja
Pending legal-status Critical Current

Links

JP2024500046A 2021-07-06 2022-07-06 ウイルス感染症の処置および予防のための組成物および方法 Pending JP2024529291A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163203026P 2021-07-06 2021-07-06
US63/203,026 2021-07-06
US202263349364P 2022-06-06 2022-06-06
US63/349,364 2022-06-06
PCT/US2022/073476 WO2023283586A2 (en) 2021-07-06 2022-07-06 Compositions and methods for treating and preventing viral infections

Publications (3)

Publication Number Publication Date
JP2024529291A JP2024529291A (ja) 2024-08-06
JP2024529291A5 JP2024529291A5 (https=) 2025-07-11
JPWO2023283586A5 true JPWO2023283586A5 (https=) 2025-07-11

Family

ID=84802047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500046A Pending JP2024529291A (ja) 2021-07-06 2022-07-06 ウイルス感染症の処置および予防のための組成物および方法

Country Status (6)

Country Link
US (1) US20240327339A1 (https=)
EP (1) EP4367086A4 (https=)
JP (1) JP2024529291A (https=)
AU (1) AU2022309236A1 (https=)
CA (1) CA3224519A1 (https=)
WO (1) WO2023283586A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117100743B (zh) * 2023-08-21 2026-03-31 海南大学 一种倍半萜内酯类化合物在制备抗病毒药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597198A (ja) * 1982-06-16 1984-01-14 ビ−チヤム・グル−プ・ピ−エルシ− 2′−デオキシウリジン化合物、その製造方法及びそれを有する製薬組成物
AU771876B2 (en) * 1998-07-27 2004-04-01 Meiji Seika Kaisha Ltd. Novel carbapenem derivatives
WO2004099127A1 (en) * 2003-05-07 2004-11-18 Novo Nordisk A/S Novel compounds as kinase inhibitors
WO2012142492A2 (en) * 2011-04-15 2012-10-18 University Of Georgia Research Foundation, Inc. Methods for inhibiting virus replication
RU2014121984A (ru) * 2011-10-31 2015-12-10 Ксенон Фармасьютикалз Инк. Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
WO2015196323A1 (zh) * 2014-06-23 2015-12-30 北京新天宇科技开发有限公司 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸的新型衍生物、其制备方法和应用
WO2016017826A1 (ja) * 2014-07-30 2016-02-04 帝人ファーマ株式会社 キサンチンオキシダーゼ阻害薬
JP7640458B2 (ja) * 2018-10-05 2025-03-05 アンナプルナ バイオ インコーポレイテッド Apj受容体活性に関連する状態を処置するための化合物および組成物
WO2021207606A1 (en) * 2020-04-10 2021-10-14 University Of Georgia Research Foundation, Inc. Methods for treatment of coronavirus infections
US11116737B1 (en) * 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Similar Documents

Publication Publication Date Title
US9283198B2 (en) Materials and methods for treating viral infections
JP2023110019A5 (https=)
JP2006527185A5 (https=)
US20120129946A1 (en) Materials and methods for treating viral infections
WO2017004499A1 (en) Compositions and methods for the treatment of viral infection
WO2022228651A1 (en) Pyruvate esters for the treatment of viral diseases
JPWO2023283586A5 (https=)
JP2010528053A (ja) インフルエンザ感染症を治療するための物質および方法
CN101340902B (zh) 用半胱胺化合物处理病毒感染的材料和方法
JP2024529291A (ja) ウイルス感染症の処置および予防のための組成物および方法
US11197912B2 (en) Prevention and treatment of viral infection and viral infection-induced organ failure
EP1596851B1 (en) The use of sodium 2-mercaptoethanesulfonate as antiviral agent
CN113730584B (zh) 双硫仑联合铜补充剂在制备抗rna病毒的药物中的应用
RU2431476C2 (ru) Материалы и способы лечения вирусных инфекций с помощью соединения цистеамина
HK1123726B (en) Materials and methods for treating viral infections with a cysteamine compound
AGENT Piazza et al.(43) Pub. Date: Aug. 24, 2006
WO2021240375A1 (en) Methotrexate for use in the pharmaceutical or veterinary prevention and/or treatment of viral infections